eli lilly compound tirzepatide finds impurity in compounded version of its weight-loss drug, warns of health risks US judge denies injunction, restricting

As the demand for GLP1 receptor agonists skyrockets, clinics across the country are facing a critical question: How can we maintain quality care without overwhelming our teams

You might worry that you couldn't drive to the hospital if you needed to if your kid was sick or something

Dan Skovronsky, Eli Lillys chief scientific and medical officer, told NBC News that retatrutide is attempting to harness the bodys own mechanisms that metabolize food and tell the body when to stop eating

A narrative review of 10 primary studies that assessed energy intakes in GLP-1 RA users revealed that total calorie intake was reduced by 16 to 39% in a single meal 25

Hnh nh: B sung c th hot cht glutathione L cht chng oxy ha mnh nht trong c th, c tc dng h tr ti a h min dch

Q: Do I need special training or certification to prescribe GLP-1 medications for weight loss